Outcomes of HIV positive patients with Cryptococcal meningitis in the absence of optimal treatment: Experience from single institution in Mexico

J Rodríguez, H Villanueva, M Martínez… - International Journal of …, 2018 - ijidonline.com
Background: In Mexico, as in other countries the treatment of Cryptococcal meningitis (CM)
is limited primarily by the high costs and availability of first line drugs. In our country …

[PDF][PDF] Neuro-psychological sequelae in HIV-negative cryptococcal meningitis after complete anti-fungal treatment

CH Chen, CC Chang, WN Chang, NW Tsai… - Acta Neurol …, 2012 - ant-tnsjournal.com
Purposes: The cognitive sequelae and influence of depression in patients with cryptococcal
meningitis (CM) after complete anti-fungal treatment has not been completely surveyed in …

[PDF][PDF] Clinical characteristics and outcomes of patients with cryptococcal meningoencephalitis in a resource-limited setting

MD Methee Chayakulkeeree, P Wangchinda - J Med Assoc Thai, 2014 - thaiscience.info
Background: Cryptococcosis is a potentially lethal opportunistic infection among human
immunodeficiency virus (HIV)-infected individuals. The mortality rate of patient with …

Comparison and correlation of magnetic resonance imaging and clinical severity in nonhuman immunodeficiency virus patients with cryptococcal infection of central …

XQ Li, S Xia, JS Ji, YH Tang, MZ Zheng, YM Li… - Chinese Medical …, 2018 - mednexus.org
Background: The incidence of cryptococcal meningitis among immunocompetent patients
increases, especially in China and imaging plays an important role. The current study was to …

[HTML][HTML] Prevalence and associated factors of cryptococcal antigenemia in HIV-infected patients with CD4< 200 cells/µL in São Paulo, Brazil: a Bayesian analysis

EV Mimicos, V Fossaluza, CM Picone, CC de Sena… - Journal of Fungi, 2022 - mdpi.com
Cryptococcosis is a severe life-threatening disease and a major cause of mortality in people
with advanced AIDS and CD4≤ 100 cells/µL. Considering the knowledge gap regarding the …

[HTML][HTML] Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis

CH Lee, TY Chang, JW Liu, FJ Chen, CC Chien… - BMC Infectious …, 2012 - Springer
Background This study aimed to investigate the correlation of minimum inhibiting
concentrations (MICs), obtained by broth micro-dilution, and clinical response in patients …

The clinical characteristics of adult cryptococcal meningitis patients who died within one year of treatment with a focus on those with early mortality

WC Tsai, CY Lien, JJ Lee, CR Huang, NW Tsai… - Journal of Clinical …, 2019 - Elsevier
Cryptococcal meningitis (CM) is a serious infectious disease of the central nervous system,
and associated brain injuries can be found in the very early stage of disease. In this study …

[HTML][HTML] Clinical characteristics and prognostic factors of 60 patients with acquired immune deficiency syndrome combined with Cryptococcus neoformans

S Liu, W Chen, F Cheng, X Ye, N Pan, H Lu - BMC Infectious Diseases, 2023 - Springer
Objective Cryptococcal meningitis (CM) threatens people's health and is the main cause of
opportunistic fungus-related death in acquired immune deficiency syndrome (AIDS) patients …

Failure of early mycological clearance in HIV-negative cryptococcal meningitis

Z Su, C Luo, K Dai, D Yuan, B Qin, M Gu… - Open Forum …, 2023 - academic.oup.com
Background. Negative cerebrospinal fluid (CSF) cultures at 2 weeks after antifungal
treatment (early mycological clearance [EMC]) should be a treatment goal of cryptococcal …

Prevalence of asymptomatic cryptococcal antigenemia and association with follow-up risk of cryptococcal meningitis and mortality among HIV infected patients in …

R Bhati, S Pramendra, B Sejoo, D Kumar… - Current HIV …, 2021 - ingentaconnect.com
Objective: Cryptococcal meningitis is an important cause of morbidity and mortality in HIV
infected individuals. In the era of universal antiretroviral therapy, the incidence of immune …